A Phase 1, Randomized, Open-Label, Crossover Study to Assess the Bioequivalence of Lesinurad Tablets From Two Manufacturing Sites in Healthy Adult Male Subjects
Phase of Trial: Phase I
Latest Information Update: 23 Sep 2014
Price : $35 *
At a glance
- Drugs Lesinurad (Primary)
- Indications Gout
- Focus Pharmacokinetics
- Sponsors Ardea Biosciences
- 21 Sep 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 11 Jun 2014 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov record.
- 05 May 2014 New trial record